PPI-delayed diagnosis of gastrinoma: Oncologic victim of pharmacologic success

Pathology and Oncology Research

Volumn 16, Issue 1, 2010, Pages 87-91

  Wong, Hilda ^a   Yau, Thomas ^a   Chan, Pierre ^a   Ng, Irene O L ^b   Chan, Gavin ^b   Hui, Peter ^b   Law, W L ^b   Lo, C M ^b   Hedley, Antony J ^b   Epstein, Richard J ^a,c  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

Gastrin; Neuroendocrine carcinoma; Omeprazole; Pancreatic tumor; Zollinger Ellison syndrome

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GASTRIN; OMEPRAZOLE; PENTETREOTIDE; RANITIDINE;

ABDOMINAL RADIOGRAPHY; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COLONOSCOPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DELAYED DIAGNOSIS; DRUG DOSE INCREASE; GASTRINOMA; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LAPAROTOMY; LIVER METASTASIS; MALE; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL HEPATECTOMY; PHYSICAL EXAMINATION; PRESCRIPTION; RADIOFREQUENCY ABLATION;

ANTI-ULCER AGENTS; APPENDECTOMY; BARRETT ESOPHAGUS; DELAYED DIAGNOSIS; GASTRINOMA; GASTROESOPHAGEAL REFLUX; HUMANS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; OMEPRAZOLE; PANCREATIC NEOPLASMS;

EID: 77949653296     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-009-9192-7     Document Type: Article

References (25)

1. EC Ellison J Sparks 2003 Zollinger-Ellison syndrome in the era of effective acid suppression: are we unknowingly growing tumors? Am J Surg 186 245 8 10.1016/S0002-9610(03)00208-3 12946826 (Pubitemid 38368623)
2. VD Corleto B Annibale F Gibril, et al. 2001 Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger-Ellison syndrome? Aliment Pharmacol Ther 15 1555 61 10.1046/j.1365-2036.2001.01085.x 1:STN:280:DC%2BD3Mrlt1enuw%3D%3D 11563994 (Pubitemid 32912397)
3. PK Roy DJ Venzon H Shojamanesh, et al. 2000 Zollinger-Ellison syndrome. Clinical presentation in 261 patients Medicine (Baltimore) 79 379 411 10.1097/00005792-200011000-00004 1:STN:280:DC%2BD3M%2FntFKisg%3D%3D
4. EH Ellison SD Wilson 1964 The Zollinger-Ellison syndrome: re-appraisal and evaluation of 260 registered cases Ann Surg 160 512 30 10.1097/00000658- 196409000-00013 1:STN:280:DyaF2M%2FhtFagtg%3D%3D 14206854
5. RM Zollinger EC Ellison TM O'Dorisio, et al. 1984 Thirty years' experience with gastrinoma World J Surg 8 427 35 10.1007/BF01654904 1:STN:280:DyaL2M%2FhvVCgtQ%3D%3D 6148806
6. RT Jensen JD Gardner JP Raufman, et al. 1983 Zollinger-Ellison syndrome: current concepts and management Ann Intern Med 98 59 75 1:STN:280: DyaL3s%2FntlSitg%3D%3D 6336642
7. DeVita VT, Lawrence TS, Rosenberg SA (2008) Cancer: principles of oncology. 8th Ed. Lippincott Williams & Welkins.
8. WC Blonski DA Katzka GR Lichtenstein, et al. 2005 Idiopathic gastric acid hypersecretion presenting as a diarrheal disorder and mimicking both Zollinger-Ellison syndrome and Crohn's disease Eur J Gastroenterol Hepatol 17 441 4 10.1097/00042737-200504000-00008 15756097 (Pubitemid 40477514)
9. PK Roy DJ Venzon KM Feigenbaum, et al. 2001 Gastric secretion in Zollinger-Ellison syndrome. Correlation with clinical expression, tumor extent and role in diagnosis - a prospective NIH study of 235 patients and a review of 984 cases in the literature Medicine (Baltimore) 80 189 222 10.1097/00005792- 200105000-00005 1:STN:280:DC%2BD3MzhsFChsg%3D%3D (Pubitemid 32466460)
10. PN Maton 1993 Use of octreotide acetate for control of symptoms in patients with islet cell tumors World J Surg 17 504 10 10.1007/BF01655110 1:STN:280:DyaK3szmvF2rsA%3D%3D 8395751
11. T Fukui A Nishio K Okazaki, et al. 2006 Gastric mucosal hyperplasia via upregulation of gastrin induced by persistent activation of gastric innate immunity in major histocompatibility complex class II deficient mice Gut 55 607 15 10.1136/gut.2005.077917 1:CAS:528:DC%2BD28Xksl2htb0%3D 16322110
12. DC Metz GM Comer E Soffer, et al. 2006 Three-year oral pantoprazole administration is effective for patients with Zollinger-Ellison syndrome and other hypersecretory conditions Aliment Pharmacol Ther 23 437 44 10.1111/j.1365-2036.2006.02762.x 1:CAS:528:DC%2BD28Xit1KjsL4%3D 16423003 (Pubitemid 43382024)
13. DC Metz MB Sostek P Ruszniewski, et al. 2007 Effects of esomeprazole on acid output in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion Am J Gastroenterol 102 2648 54 10.1111/j.1572-0241.2007. 01509.x 1:CAS:528:DC%2BD1cXkvVCksg%3D%3D 17764495 (Pubitemid 350179329)
14. M Banasch F Schmitz 2007 Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors Wien Klin Wochenschr 119 573 8 10.1007/s00508-007- 0884-2 1:CAS:528:DC%2BD1cXksl2qsg%3D%3D 17985090 (Pubitemid 350060665)
15. MB Lodish AC Powell M Abu-Asab, et al. 2008 Insulinoma and gastrinoma syndromes from a single intrapancreatic neuroendocrine tumor J Clin Endocrinol Metab 93 1123 8 10.1210/jc.2007-2449 1:CAS:528:DC%2BD1cXks1ahtb4%3D 18252785
16. L Gurevich I Kazantseva VA Isakov, et al. 2003 The analysis of immunophenotype of gastrin-producing tumors of the pancreas and gastrointestinal tract Cancer 98 1967 76 10.1002/cncr.11739 14584081 (Pubitemid 37310241)
17. T Bamba S Kosugi T Kanda, et al. 2007 Multiple carcinoids in the duodenum, pancreas and stomach accompanied with type A gastritis: a case report World J Gastroenterol 13 2247 9 17465512
18. JE Ardill B Erikkson 2003 The importance of the measurement of circulating markers in patients with neuroendocrine tumours of the pancreas and gut Endocr Relat Cancer 10 459 62 10.1677/erc.0.0100459 1:CAS:528: DC%2BD2cXht1eitrc%3D 14713258 (Pubitemid 38094882)
19. F Gibril JC Reynolds JL Doppman, et al. 1996 Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas A prospective study Ann Intern Med 125 26 34 1:STN:280:DyaK283ksFSkug%3D%3D 8644985
20. T Zimmer U Stolzel M Bader, et al. 1996 Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas Gut 39 562 8 10.1136/gut.39.4.562 1:STN:280:DyaK2s%2FpvF2quw%3D%3D 8944566
21. HR Alexander DL Fraker JA Norton, et al. 1998 Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome Ann Surg 228 228 38 10.1097/00000658-199808000-00013 1:STN:280:DyaK1czns1Citg%3D%3D 9712569 (Pubitemid 30191719)
22. NW Thompson FE Eckhauser AI Vinik, et al. 1984 Cystic neuroendocrine neoplasms of the pancreas and liver Ann Surg 199 158 64 10.1097/00000658- 198402000-00004 1:STN:280:DyaL2c7islSmsg%3D%3D 6141769
23. S van Santen EJ van Soest OR Busch, et al. 2007 A woman with shock as first sign of Zollinger-Ellison syndrome Ned Tijdschr Geneeskd 151 478 83 17378305
24. A Tartaglia C Vezzadini S Bianchini, et al. 2005 Gastrinoma of the stomach: a case report Int J Gastrointest Cancer 35 211 6 10.1385/IJGC:35:3:211 16110123
25. JA Norton DL Fraker HR Alexander, et al. 1999 Surgery to cure the Zollinger-Ellison syndrome N Engl J Med 341 635 44 10.1056/NEJM199908263410902 1:STN:280:DyaK1MzotlKnsQ%3D%3D 10460814 (Pubitemid 29399042)